SCOHIA PHARMA, Inc.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
SCOHIA PHARMA, Inc. is a biotech venture with substantial research and development capabilities for drug discovery in the field of cardiovascular, metabolic and renal areas. Initiated operations in April 2017 by carving out from Takeda Pharmaceutical Company Limited with highly talented and experienced human resources as well as multiple pre-clinical and clinical assets, we strive for delivering truly efficacious and innovative therapeutic medicine to the patients around the world.
We are funded by three major Japanese companies: Innovation Network Corporation of Japan (now INCJ, Ltd.), Takeda Pharmaceutical Company Limited and MEDIPAL HOLDINGS CORPORATION.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
SCO-272
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided